These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 15941870

  • 1. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [Abstract] [Full Text] [Related]

  • 2. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
    [Abstract] [Full Text] [Related]

  • 3. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC.
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [Abstract] [Full Text] [Related]

  • 4. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W, Tan J, Wang P, Wu P.
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [Abstract] [Full Text] [Related]

  • 5. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 6. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R, Haberkorn U.
    J Nucl Med; 2006 May 01; 47(5):854-62. PubMed ID: 16644756
    [Abstract] [Full Text] [Related]

  • 7. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC.
    Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711
    [Abstract] [Full Text] [Related]

  • 8. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Romijn JA, van der Heide D.
    Exp Clin Endocrinol Diabetes; 2001 Nov 15; 109(1):52-5. PubMed ID: 11573141
    [Abstract] [Full Text] [Related]

  • 9. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 15; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
    Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Göke B, Morris JC.
    Endocrinology; 2003 Aug 15; 144(8):3423-32. PubMed ID: 12865321
    [Abstract] [Full Text] [Related]

  • 11. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
    Yao C, Pan Y, Li Y, Xu X, Lin Y, Wang W, Wang S.
    Oncol Rep; 2015 Jul 15; 34(1):59-66. PubMed ID: 25955347
    [Abstract] [Full Text] [Related]

  • 12. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
    Unterholzner S, Willhauck MJ, Cengic N, Schütz M, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2006 Jan 15; 91(1):69-78. PubMed ID: 16234306
    [Abstract] [Full Text] [Related]

  • 14. Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
    Chung T, Youn H, Yeom CJ, Kang KW, Chung JK.
    PLoS One; 2015 Jan 15; 10(11):e0142984. PubMed ID: 26599396
    [Abstract] [Full Text] [Related]

  • 15. Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.
    Li W, Venkataraman GM, Ain KB.
    J Clin Endocrinol Metab; 2007 Mar 15; 92(3):1080-7. PubMed ID: 17164311
    [Abstract] [Full Text] [Related]

  • 16. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
    Li W, Tan J, Wang P, Li N, Li C.
    Mol Cell Biochem; 2015 Jan 15; 399(1-2):279-89. PubMed ID: 25410753
    [Abstract] [Full Text] [Related]

  • 17. Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
    So Y, Lee YJ, Lee WW, Chung JK.
    Oncol Rep; 2013 Apr 15; 29(4):1666-70. PubMed ID: 23404348
    [Abstract] [Full Text] [Related]

  • 18. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Stokkel M, van der Heide D, Romijn JA.
    J Clin Endocrinol Metab; 2002 Mar 15; 87(3):1247-53. PubMed ID: 11889195
    [Abstract] [Full Text] [Related]

  • 19. Expression of the sodium iodide symporter in human kidney.
    Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC.
    Kidney Int; 2001 Mar 15; 59(3):1013-23. PubMed ID: 11231356
    [Abstract] [Full Text] [Related]

  • 20. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ, Huang R, Kuang AR.
    Cancer Invest; 2009 Jul 15; 27(6):673-81. PubMed ID: 19241193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.